Inventor
MAO LONG
CN27 patents
⚠️ This page may combine multiple inventors who share the name “MAO LONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACEA BIOSCIENCES INC
10 patentsUS8685988B2Apr 1, 2014
EGFR modulators and uses thereof
ACEA BIOSCIENCES INC11 citations92
US10596174B2Mar 24, 2020
Pyrrolopyrimidine compounds as inhibitors of protein kinases
ACEA BIOSCIENCES INC4 citations84
US9920074B2Mar 20, 2018
Heterocyclic compounds and uses thereof
ACEA BIOSCIENCES INC6 citations84
US9763949B2Sep 19, 2017
EGFR modulators and uses thereof
ACEA BIOSCIENCES INC8 citations84
US9586965B2Mar 7, 2017
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
ACEA BIOSCIENCES INC8 citations84
US9464089B2Oct 11, 2016
Heterocyclic compounds and uses thereof
ACEA BIOSCIENCES INC12 citations84
US9034885B2May 19, 2015
EGFR modulators and uses thereof
ACEA BIOSCIENCES INC11 citations84
US10799504B2Oct 13, 2020
Heterocyclic compounds and uses as anticancer agents
ACEA BIOSCIENCES INC2 citations73
US10562918B2Feb 18, 2020
Heterocyclic compounds and uses thereof
ACEA BIOSCIENCES INC3 citations73
US10449196B2Oct 22, 2019
EGFR modulators and uses thereof
ACEA BIOSCIENCES INC3 citations73
ACEA THERAPEUTICS INC
7 patentsUS11007197B2May 18, 2021
EGFR modulators and uses thereof
ACEA THERAPEUTICS INC2 citations72
US10533011B2Jan 14, 2020
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
ACEA THERAPEUTICS INC4 citations67
US11612602B2Mar 28, 2023
Heterocyclic compounds and uses as anticancer agents
ACEA THERAPEUTICS INC0 citations62
US11987554B2May 21, 2024
Protease inhibitors as antivirals
ACEA THERAPEUTICS INC0 citations57
US11753373B2Sep 12, 2023
Protease inhibitors as antivirals
ACEA THERAPEUTICS INC0 citations57
US12358895B2Jul 15, 2025
Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof
ACEA THERAPEUTICS INC0 citations55
US11498922B2Nov 15, 2022
Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide
ACEA THERAPEUTICS INC0 citations45